These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22941279)

  • 1. Identification of a boron nitride nanosphere-binding peptide for the intracellular delivery of CpG oligodeoxynucleotides.
    Zhang H; Yamazaki T; Zhi C; Hanagata N
    Nanoscale; 2012 Oct; 4(20):6343-50. PubMed ID: 22941279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
    Zhang H; Feng S; Yan T; Zhi C; Gao XD; Hanagata N
    Int J Nanomedicine; 2015; 10():5343-53. PubMed ID: 26346655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines.
    Zhang H; Chen S; Zhi C; Yamazaki T; Hanagata N
    Int J Nanomedicine; 2013; 8():1783-93. PubMed ID: 23674892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BN nanospheres functionalized with mesoporous silica for enhancing CpG oligodeoxynucleotide-mediated cancer immunotherapy.
    Zhang H; Cheng T; Lai L; Deng S; Yu R; Qiu L; Zhou J; Lu G; Zhi C; Chen J
    Nanoscale; 2018 Aug; 10(30):14516-14524. PubMed ID: 30024003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune responses triggered by CpG ODNs in shrimp Litopenaeus vannamei are associated with LvTolls.
    Sun R; Wang M; Wang L; Yue F; Yi Q; Huang M; Liu R; Qiu L; Song L
    Dev Comp Immunol; 2014 Mar; 43(1):15-22. PubMed ID: 24176974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs.
    Feng S; Zhang H; Yan T; Huang D; Zhi C; Nakanishi H; Gao XD
    Int J Nanomedicine; 2016; 11():4573-4582. PubMed ID: 27695318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model.
    Smith RL; Chong TW; Hughes MG; Hedrick TL; Evans HL; McElearney ST; Saalwachter AR; Raymond DP; Du K; Rudy CK; Pruett TL; Sawyer RG
    Surgery; 2004 Aug; 136(2):464-72. PubMed ID: 15300216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
    Meng W; Yamazaki T; Nishida Y; Hanagata N
    BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
    J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif.
    Zhang Z; Guo K; Schluesener HJ
    J Neuroimmunol; 2005 Apr; 161(1-2):68-77. PubMed ID: 15748945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CpG oligodeoxynucleotide sequences that induce IFN-gamma production in canine peripheral blood mononuclear cells.
    Kurata K; Iwata A; Masuda K; Sakaguchi M; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2004 Dec; 102(4):441-50. PubMed ID: 15541797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of nitric oxide production to CpG oligodeoxynucleotides in turkey and chicken peripheral blood monocytes.
    He H; Genovese KJ; Lowry VK; Nisbet DJ; Kogut MH
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):99-106. PubMed ID: 16965357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production.
    Nardini E; Morelli D; Aiello P; Besusso D; Calcaterra C; Mariani L; Palazzo M; Vecchi A; Paltrinieri S; Menard S; Balsari A
    J Cell Physiol; 2005 Sep; 204(3):889-95. PubMed ID: 15828023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
    Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
    J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides.
    Zhang H; Yan T; Xu S; Feng S; Huang D; Fujita M; Gao XD
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():144-151. PubMed ID: 28183591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
    Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
    Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.